$4.39 -0.15 (-3.30%)
11/27/2009 12:57 PM

Nymox Pharmaceutical Corp (NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Featured Broker Partners